| 0 |
OFF LABEL USE |
92 |
| 1 |
UNDERDOSE |
62 |
| 2 |
LABORATORY TEST INTERFERENCE |
58 |
| 3 |
ACUTE KIDNEY INJURY |
36 |
| 4 |
BLOOD CREATININE INCREASED |
34 |
| 5 |
TOXICITY TO VARIOUS AGENTS |
34 |
| 6 |
DRUG EFFECT INCOMPLETE |
33 |
| 7 |
REBOUND EFFECT |
33 |
| 8 |
DRUG INEFFECTIVE |
31 |
| 9 |
DEATH |
27 |
| 10 |
RENAL FAILURE |
25 |
| 11 |
MUCOSAL INFLAMMATION |
23 |
| 12 |
DRUG LEVEL INCREASED |
16 |
| 13 |
ALANINE AMINOTRANSFERASE INCREASED |
15 |
| 14 |
FALSE POSITIVE INVESTIGATION RESULT |
15 |
| 15 |
PANCYTOPENIA |
15 |
| 16 |
NO ADVERSE EVENT |
14 |
| 17 |
PRODUCT USE IN UNAPPROVED INDICATION |
14 |
| 18 |
TOXIC EPIDERMAL NECROLYSIS |
14 |
| 19 |
NEPHROPATHY TOXIC |
13 |
| 20 |
RENAL IMPAIRMENT |
13 |
| 21 |
ASPARTATE AMINOTRANSFERASE INCREASED |
11 |
| 22 |
HYPERVOLAEMIA |
11 |
| 23 |
NEUTROPENIA |
11 |
| 24 |
DRUG CLEARANCE DECREASED |
9 |
| 25 |
DRUG INTERACTION |
9 |
| 26 |
RENAL FAILURE ACUTE |
9 |
| 27 |
ENCEPHALOPATHY |
8 |
| 28 |
THROMBOCYTOPENIA |
8 |
| 29 |
CONDITION AGGRAVATED |
7 |
| 30 |
DISEASE PROGRESSION |
7 |
| 31 |
FLUID OVERLOAD |
7 |
| 32 |
PLEURAL EFFUSION |
7 |
| 33 |
BLOOD BILIRUBIN INCREASED |
6 |
| 34 |
CONTRAINDICATED PRODUCT ADMINISTERED |
6 |
| 35 |
PRESCRIBED UNDERDOSE |
6 |
| 36 |
ABDOMINAL PAIN |
5 |
| 37 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
5 |
| 38 |
FLUID RETENTION |
5 |
| 39 |
HYPOTENSION |
5 |
| 40 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
5 |
| 41 |
OVERDOSE |
5 |
| 42 |
ANAEMIA |
4 |
| 43 |
BONE MARROW FAILURE |
4 |
| 44 |
DYSPNOEA |
4 |
| 45 |
GASTROINTESTINAL HAEMORRHAGE |
4 |
| 46 |
HAEMODIALYSIS |
4 |
| 47 |
HEPATOCELLULAR INJURY |
4 |
| 48 |
HYPERTRANSAMINASAEMIA |
4 |
| 49 |
HYPOXIA |
4 |
| 50 |
INCORRECT DOSE ADMINISTERED |
4 |
| 51 |
INTERNATIONAL NORMALISED RATIO INCREASED |
4 |
| 52 |
NEUROTOXICITY |
4 |
| 53 |
OEDEMA |
4 |
| 54 |
PNEUMONIA |
4 |
| 55 |
SEIZURE |
4 |
| 56 |
SEPSIS |
4 |
| 57 |
SEPTIC SHOCK |
4 |
| 58 |
THERAPY CHANGE |
4 |
| 59 |
AGITATION |
3 |
| 60 |
ANURIA |
3 |
| 61 |
AZOTAEMIA |
3 |
| 62 |
CONFUSIONAL STATE |
3 |
| 63 |
CRYSTAL NEPHROPATHY |
3 |
| 64 |
DRUG EFFECT DECREASED |
3 |
| 65 |
DYSARTHRIA |
3 |
| 66 |
HYPERKALAEMIA |
3 |
| 67 |
HYPERTENSION |
3 |
| 68 |
INTENTIONAL PRODUCT USE ISSUE |
3 |
| 69 |
LIVER DISORDER |
3 |
| 70 |
MENTAL STATUS CHANGES |
3 |
| 71 |
METABOLIC ACIDOSIS |
3 |
| 72 |
NON-HODGKIN^S LYMPHOMA |
3 |
| 73 |
PRODUCT AVAILABILITY ISSUE |
3 |
| 74 |
PULMONARY OEDEMA |
3 |
| 75 |
PYREXIA |
3 |
| 76 |
RASH ERYTHEMATOUS |
3 |
| 77 |
RESPIRATORY FAILURE |
3 |
| 78 |
STAPHYLOCOCCAL BACTERAEMIA |
3 |
| 79 |
STAPHYLOCOCCAL INFECTION |
3 |
| 80 |
SUBDURAL HAEMATOMA |
3 |
| 81 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
3 |
| 82 |
THERAPEUTIC RESPONSE DECREASED |
3 |
| 83 |
THERAPY PARTIAL RESPONDER |
3 |
| 84 |
VOMITING |
3 |
| 85 |
ACIDOSIS |
2 |
| 86 |
ALKALOSIS |
2 |
| 87 |
ANAPHYLACTIC REACTION |
2 |
| 88 |
ASCITES |
2 |
| 89 |
BILIRUBIN CONJUGATED INCREASED |
2 |
| 90 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
2 |
| 91 |
BRAIN OEDEMA |
2 |
| 92 |
CARDIOGENIC SHOCK |
2 |
| 93 |
CEREBRAL HAEMORRHAGE |
2 |
| 94 |
CEREBROVASCULAR ACCIDENT |
2 |
| 95 |
CHEMOTHERAPEUTIC DRUG LEVEL INCREASED |
2 |
| 96 |
CLOSTRIDIUM DIFFICILE COLITIS |
2 |
| 97 |
CONTINUOUS HAEMODIAFILTRATION |
2 |
| 98 |
CRYSTALLURIA |
2 |
| 99 |
DIALYSIS |
2 |
| 100 |
DRUG ERUPTION |
2 |
| 101 |
DRUG-INDUCED LIVER INJURY |
2 |
| 102 |
DYSPHAGIA |
2 |
| 103 |
EPIDERMAL NECROSIS |
2 |
| 104 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
2 |
| 105 |
GLOMERULAR FILTRATION RATE DECREASED |
2 |
| 106 |
HEPATIC FAILURE |
2 |
| 107 |
HEPATIC FUNCTION ABNORMAL |
2 |
| 108 |
HEPATOTOXICITY |
2 |
| 109 |
HOSPITALISATION |
2 |
| 110 |
HYPERSENSITIVITY |
2 |
| 111 |
INTENTIONAL UNDERDOSE |
2 |
| 112 |
LIVER INJURY |
2 |
| 113 |
LOSS OF CONSCIOUSNESS |
2 |
| 114 |
MALAISE |
2 |
| 115 |
MALIGNANT NEOPLASM PROGRESSION |
2 |
| 116 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
2 |
| 117 |
MYELOSUPPRESSION |
2 |
| 118 |
NO THERAPEUTIC RESPONSE |
2 |
| 119 |
PRESCRIBED OVERDOSE |
2 |
| 120 |
PRODUCT QUALITY ISSUE |
2 |
| 121 |
RASH VESICULAR |
2 |
| 122 |
RENAL PAIN |
2 |
| 123 |
RESPIRATORY ARREST |
2 |
| 124 |
RESPIRATORY DISTRESS |
2 |
| 125 |
STATUS EPILEPTICUS |
2 |
| 126 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
2 |
| 127 |
TOXIC ENCEPHALOPATHY |
2 |
| 128 |
TOXIC SKIN ERUPTION |
2 |
| 129 |
TREATMENT DELAYED |
2 |
| 130 |
UNRESPONSIVE TO STIMULI |
2 |
| 131 |
URINE OUTPUT DECREASED |
2 |
| 132 |
WEIGHT INCREASED |
2 |
| 133 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
1 |
| 134 |
AGGRESSION |
1 |
| 135 |
ALANINE AMINOTRANSFERASE ABNORMAL |
1 |
| 136 |
ALTERED STATE OF CONSCIOUSNESS |
1 |
| 137 |
AMNESIA |
1 |
| 138 |
ARACHNOIDITIS |
1 |
| 139 |
ARRHYTHMIA |
1 |
| 140 |
ASPARTATE AMINOTRANSFERASE ABNORMAL |
1 |
| 141 |
ASTERIXIS |
1 |
| 142 |
ATAXIA |
1 |
| 143 |
ATRIAL FIBRILLATION |
1 |
| 144 |
BACTERAEMIA |
1 |
| 145 |
BACTERIAL SEPSIS |
1 |
| 146 |
BEDRIDDEN |
1 |
| 147 |
BLOOD ALBUMIN DECREASED |
1 |
| 148 |
BLOOD CHOLESTEROL ABNORMAL |
1 |
| 149 |
BLOOD COUNT ABNORMAL |
1 |
| 150 |
BLOOD CULTURE POSITIVE |
1 |
| 151 |
BLOOD ELECTROLYTES ABNORMAL |
1 |
| 152 |
BLOOD TRIGLYCERIDES ABNORMAL |
1 |
| 153 |
BLOOD UREA INCREASED |
1 |
| 154 |
CARDIAC ARREST |
1 |
| 155 |
CARDIAC FAILURE |
1 |
| 156 |
CARDIO-RESPIRATORY ARREST |
1 |
| 157 |
CARDIORENAL SYNDROME |
1 |
| 158 |
CEREBROSPINAL FLUID LEAKAGE |
1 |
| 159 |
CLOSTRIDIUM DIFFICILE INFECTION |
1 |
| 160 |
CORONARY ARTERY DISEASE |
1 |
| 161 |
COUGH |
1 |
| 162 |
CYTOPENIA |
1 |
| 163 |
DEEP VEIN THROMBOSIS |
1 |
| 164 |
DEMENTIA |
1 |
| 165 |
DERMATITIS |
1 |
| 166 |
DIABETES MELLITUS |
1 |
| 167 |
DRUG EFFECT DELAYED |
1 |
| 168 |
DRUG HYPERSENSITIVITY |
1 |
| 169 |
DRUG LEVEL DECREASED |
1 |
| 170 |
DRUG LEVEL FLUCTUATING |
1 |
| 171 |
ELECTROLYTE IMBALANCE |
1 |
| 172 |
EROSIVE OESOPHAGITIS |
1 |
| 173 |
EXTRA DOSE ADMINISTERED |
1 |
| 174 |
FATIGUE |
1 |
| 175 |
FEBRILE NEUTROPENIA |
1 |
| 176 |
FRONTOTEMPORAL DEMENTIA |
1 |
| 177 |
GAIT DISTURBANCE |
1 |
| 178 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
| 179 |
GENERALISED OEDEMA |
1 |
| 180 |
GENERALISED TONIC-CLONIC SEIZURE |
1 |
| 181 |
GENITAL EROSION |
1 |
| 182 |
HAEMODYNAMIC INSTABILITY |
1 |
| 183 |
HEADACHE |
1 |
| 184 |
HEPATIC STEATOSIS |
1 |
| 185 |
HEPATOMEGALY |
1 |
| 186 |
HEPATORENAL SYNDROME |
1 |
| 187 |
HERPES ZOSTER |
1 |
| 188 |
HYPOKALAEMIA |
1 |
| 189 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
1 |
| 190 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
1 |
| 191 |
INFUSION RELATED REACTION |
1 |
| 192 |
INFUSION SITE REACTION |
1 |
| 193 |
INJECTION SITE INFECTION |
1 |
| 194 |
INTENTIONAL PRODUCT MISUSE |
1 |
| 195 |
LEUKAEMIC LYMPHOMA |
1 |
| 196 |
LOWER RESPIRATORY TRACT INFECTION |
1 |
| 197 |
MEDICATION ERROR |
1 |
| 198 |
NAUSEA |
1 |
| 199 |
NECK PAIN |
1 |
| 200 |
NEUROLOGICAL DECOMPENSATION |
1 |
| 201 |
NEUTROPHIL COUNT DECREASED |
1 |
| 202 |
NEUTROPHIL COUNT INCREASED |
1 |
| 203 |
OEDEMA PERIPHERAL |
1 |
| 204 |
OLIGURIA |
1 |
| 205 |
ORAL MUCOSA EROSION |
1 |
| 206 |
OSTEONECROSIS OF JAW |
1 |
| 207 |
OSTEOSARCOMA METASTATIC |
1 |
| 208 |
OSTEOSARCOMA RECURRENT |
1 |
| 209 |
OXYGEN SATURATION DECREASED |
1 |
| 210 |
PERICARDIAL EFFUSION |
1 |
| 211 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
1 |
| 212 |
PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION |
1 |
| 213 |
PRODUCT ADMINISTRATION ERROR |
1 |
| 214 |
PRODUCT PRESCRIBING ERROR |
1 |
| 215 |
PRODUCT SUPPLY ISSUE |
1 |
| 216 |
PROTHROMBIN LEVEL DECREASED |
1 |
| 217 |
PROTHROMBIN TIME PROLONGED |
1 |
| 218 |
PSYCHOTIC DISORDER |
1 |
| 219 |
PULMONARY EMBOLISM |
1 |
| 220 |
PULSE ABSENT |
1 |
| 221 |
RADIOTHERAPY |
1 |
| 222 |
RASH |
1 |
| 223 |
RECTAL HAEMORRHAGE |
1 |
| 224 |
RENAL DISORDER |
1 |
| 225 |
RENAL TUBULAR NECROSIS |
1 |
| 226 |
RESPIRATORY DEPRESSION |
1 |
| 227 |
RESUSCITATION |
1 |
| 228 |
SKIN EXFOLIATION |
1 |
| 229 |
SKIN INFECTION |
1 |
| 230 |
SKIN LESION |
1 |
| 231 |
SYSTEMIC CANDIDA |
1 |
| 232 |
TACHYCARDIA |
1 |
| 233 |
THERAPEUTIC RESPONSE UNEXPECTED |
1 |
| 234 |
THROMBOSIS |
1 |
| 235 |
TOXIC LEUKOENCEPHALOPATHY |
1 |
| 236 |
TRANSAMINASES INCREASED |
1 |
| 237 |
URINARY RETENTION |
1 |
| 238 |
URINARY TRACT INFECTION |
1 |
| 239 |
URINE OUTPUT |
1 |
| 240 |
VENTRICULAR TACHYCARDIA |
1 |
| 241 |
WALKING AID USER |
1 |
| 242 |
WHITE BLOOD CELL COUNT INCREASED |
1 |